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ABSTRACT: Seven new bisbibenzyls (1−7) were isolated from
the methanol extract of the liverwort Lunularia cruciata along with
one previously known bibenzyl and ﬁve known bisbibenzyls. The
structures of compounds 1−7 were elucidated on the basis of the
spectroscopic data. These newly isolated bisbibenzyls may be
divided into two groups, the acyclic bisbibenzyls, perrottetins (1−
3), and the cyclic analogues, riccardins (4−7). Besides standard
perrottetin and riccardin structures (1 and 4, respectively), they
contain phenanthrene (3 and 5), dihydrophenanthrene (2), and
quinone moieties (6 and 7), rarely found in natural products. The
new compounds 3 and 5, as well as the known riccardin G,
exhibited cytotoxic activity against the A549 lung cancer cell line
with IC50 values of 5.0, 5.0, and 2.5 μM, respectively.
The liverworts (Marchantiophyta) are rich sources ofbisbibenzyls and their derivatives. So far, more than 60
macrocyclic and acyclic bisbibenzyls have been isolated from
various liverwort species.1,2 Generally, they are active as
antimicrobial, antioxidant, antitrypanosomal, antiviral, and
cytotoxic agents. In addition, they possess farnesoid X-receptor
(FXR) receptor activity, liver-X-activity, muscle relaxing and
calcium inhibitory, nitric oxide production inhibitory, tubulin
inhibitory, and cardiotonic activities.2
Lunularia cruciata (L.) Dumort. ex Lindb. (Lunulariaceae) is
a thalloid liverwort characterized by crescent-shaped cups that
contain gemmae (small vegetative propagules), used for
asexual reproduction. The thallus surface of this liverwort is
dotted with tiny pores that are framed by pentagon-shaped
boundaries. It is a dioecious plant with thalli that are 5−10 mm
wide and up to 2.5 cm long and is irregularly dichotomously
branched. L. cruciata is the sole species in the genus Lunularia.3
Chemical analysis of the Japanese L. cruciata has revealed the
presence of lunularin, lunularic acid, bisbibenzyls, perrottetin
F, and its derivatives.2,4 Jockovic et al. noted the presence of
two ﬂavonoids, luteolin-7-O-glucoside and quercetin, in the
methanol extract of European L. cruciata.5 The crude extracts
of L. cruciata showed antimicrobial activity against selected
pathogenic bacteria.6,7 Lunularin isolated from a vascular plant,
Melampyrum pratense, inhibited E-selectin and interleukin-8
expression after stimulation with lipopolysaccharide, suggesting
its potential anti-inﬂammatory activity.8 Perrottetin F showed
anti-inﬂuenza PA endonuclease activity.9 Riccardin C exhibited
cytotoxicity for a prostate cancer cell line and anti-MRSA
activity.10,11 Riccardins C and F were identiﬁed as an LXRa
agonist/LXRb antagonist and an LXRa antagonist, respec-
tively.12 Riccardin D, a demethylated derivative of riccardin G,
has shown inhibitory eﬀects on several diﬀerent types of
human cancer cells.13−17
Reported herein are the isolation and structure elucidation
of seven new chemical constituents of L. cruciata. Three of
them belong to perrottetin-type (1−3) and four are riccardin-
type bisbibenzyls (4−7). Additionally, six previously reported
compounds, one bibenzyl and ﬁve bisbibenzyls, were also
isolated. Cytotoxic activity of all of the isolated compounds
against two human cell lines, A549 (lung carcinoma) and
MRC5 (healthy lung ﬁbroblasts), was also investigated.
■ RESULTS AND DISCUSSION
The methanol extract of L. cruciata was fractionated by a
combination of silica gel CC, preparative silica gel TLC, and
semipreparative reversed-phase HPLC to aﬀord seven new
bisbibenzyls (1−7), one known bibenzyl (lunularin), and ﬁve
known bisbibenzyls (perrottetins E and F and riccardins C, F,
and G, respectively). Lunularin was found to be a constituent
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of celery18 and Morus species among vascular plants,19 but is
mainly distributed in the Hepaticae.20 It was detected in the
liverwort Conocephalum conicum as a decarboxylated product of
lunularic acid.21 Perrottetins E and F are bisbibenzyls isolated
initially from the liverwort Radula perrottetii,22 with riccardin C
obtained from Reboulia hemisphaerica,23 riccardin F from Blasia
pusilla,24 and riccardin G from Marchantia chenopoda.25
Subsequently, these compounds have been found in a several
more liverwort species,1,2 but all these six known compounds
are now being reported for the ﬁrst time in L. cruciata. The
assignment of NMR data of 1−7 (Tables 1 and 2) was based
on 2D NMR methods, as well as comparison to those of the
known co-occurrinig bisbibenzyls.21−25
Compound 1, isolated as a brown amorphous substance, was
found to possess the molecular formula C29H27O6, on the basis
of the [M − H]− molecular ion peak at m/z 471.1827 of its
negative HRESIMS and from the 13C NMR spectrum, as
shown in Table 1. The UV bands at 272 and 282 nm and the
IR absorption bands at 3422, 1609, and 1593 cm−1 indicated
the presence of a phenolic moiety in 1. The 1H NMR chemical
shifts and coupling constants of the protons of the A-, B-, and
D-rings of 1 were very similar to those of perrottetin F.22 The
major diﬀerences between the spectra of these compounds
were due to an additional three-proton singlet of a methoxy
group (δH, 3.15; δC, 56.8) and one-proton triplet signal (δH,
4.12, H-7′) bonded to an oxygenated carbon. The 2D NMR
data revealed their position at C-7′, as observed by the COSY
correlations H-7′/H-8′a, H-8′b, the HMBC cross-peaks H-3′,
H-5′, H-8′/C-7′, and the NOE correlations OMe-7′/H-7′, H-
5′, H-3′ (Figures S5, S8, and S11, Supporting Information).
Thus, the structure of the new bisbibenzyl, 1, was established
as 7′-methoxyperrottetin F. The absolute conﬁguration at C-7′
remains to be clariﬁed. There is a possibility that 1 could be an
artifact of 7′-hydroxyperrottetin F, which was transformed to
the methoxy derivative during the isolation procedure, as seen
for the bisbibenzyl marchantin G.1
Compound 2 was isolated as an amorphous violet substance.
Its negative-mode HRESIMS exhibited a [M − H]− molecular
ion peak at m/z 423.1610 and, together with the 13C NMR
spectrum, showed a molecular formula of C28H24O4. The UV
bands at 278, 294 (sh), and 320 nm were characteristic for an
extended conjugation. The 1H NMR spectrum of 2 was similar
to that of perrottetin F22 and compound 1, with the protons of
the A- and B-rings exhibiting the same pattern. The molecular
formula, when compared to that of 1, indicated one additional
unsaturation or a ring, i.e, direct coupling between the C- and
D-rings. When comparing the 1H NMR spectrum of 2 and 1, a
one-proton singlet at δH 6.59 appeared instead of the
characteristic doublet (J = 2.0 Hz) for H-3′ (Table 1). A
strong HMBC correlation of this proton to C-7′ (Figure S22,
Supporting Information) conﬁrmed its assignment as H-3′. At
the same time, a singlet at δH 7.14 could be assigned to H-6′.
The HMBC cross-peaks between H-12′, H-10′, H-6′/C-14′
and H-13′, H-3′/C-5′ and the strong NOE correlations of H-
Table 1. 1H and 13C NMR Data of Compounds 1−3 Recorded in CD3OD (500 MHz for 1H and 125 MHz for 13C)a
1 2 3
position δC δH δC δH δC δH
1 157.4 155.0 157.1
2 118.5 6.73 d (9.0) 115.6 6.76 d (9.0) 116.2 6.74 d (9.0)
3 130.6 7.07 d (9.0) 127.9 7.01 d (9.0) 130.5 7.02 d (9.0)
4 137.4 134.6 136.6
5 130.6 7.07 d (9.0) 127.9 7.01 d (9.0) 130.5 7.02 d (9.0)
6 118.5 6.73 d (9.0) 115.6 6.76 d (9.0) 116.2 6.74 d (9.0)
7 38.3 2.82 m 35.5 2.75 m 38.3 2.75 m
8 39.4 2.80 m 36.5 2.71 m 39.4 2.75 m
9 144.8 141.9 144.9
10 116.5 6.62 t (2.0) 113.7 6.51 brs 116.4 6.60 m
11 158.5 155.6 158.4
12 113.9 6.58 mb 111.0 6.49 dd (8.0; 2.0) 113.9 6.55 m
13 130.4 7.04 t (7.5) 127.5 6.95 t (8.0) 130.3 7.00 t (8.0)
14 121.0 6.64 dt (7.5) 118.1 6.55 mc 121.0 6.57 m
1′ 137.6 146.0 141.2
2′ 145.7 141.0 139.9
3′ 111.6 6.13 d (2.0) 118.1 6.59 s 120.4
4′ 133.7 126.9 127.5
5′ 110.3 6.56 d (2.0) 129.9 110.8 7.18 s
6′ 148.1 109.7 7.14 s 147.1
7′ 86.4 4.12 t (7.5) 26.7 2.55 m 127.9 7.49 d (9.0)
8′ 45.5 2.70 dd (13.0; 7.5) 28.0 2.62 m 125.9 7.38 d (9.0)
2.98 dd (13.0; 7.5)
9′ 141.1 137.2 135.4
10′ 117.6 6.47 brt 113.0 6.55 brsc 112.4 6.87 d (2.5)
11′ 158.2 155.1 155.9
12′ 114.2 6.56 mb 112.1 6.60 dd (8.0; 2.0) 117.3 6.87 dd (9.5; 2.5)
13′ 130.2 6.99 t (7.5) 123.0 7.40 d (8.0) 129.5 8.95 d (9.5)
14′ 122.1 6.50 dt (7.5) 124.6 123.9
OMe-7′ 56.8 3.15 s
aJ values are given in parentheses. b,cSignals overlapped.
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6′/H-13′ and H-3′/H-6, H-7′ supported a dihydrophenan-
threne structure of the C- and D-rings in a perrottetin skeleton,
indicating 2 is an intramolecular C-5′−C-14′ coupling product
of perrottetin E (Figures 1 and S22, S19, and S20, Supporting
Information). Similar dihydrophenanthrene bisbibenzyl deriv-
atives, 2′-(11-hydroxy-1-bibenzyloxy)-1′-methoxy-6′,10′,11′-
trihydroxy-7′,8′-dihydrophenanthrene and 2′-(10,11-dihy-
droxy-1-bibenzyloxy)-1′-methoxy-6′,10′,11′-trihydroxy-7′,8′-
dihydrophenanthrene, were found in the methanol extract of
the Ecuadorian liverwort Frullania convoluta, along with
lunularin and lunularic acid.26
Compound 3 was isolated as an amorphous violet substance.
Its negative-mode HRESIMS exhibited a [M − H]− molecular
ion peak at m/z 437.1405, which together with the 13C NMR
spectrum was consistent with the molecular formula C28H22O5.
The UV bands at 256, 272 (sh), 284 (sh), 308 (sh), 348, and
362 nm were characteristic for the occurrence of more
extended conjugation than found in 2. This was in agreement
with the molecular formula, which revealed one additional
degree of unsaturation in comparison to that in 2. The 1H
NMR spectrum of 3 exhibited the presence of aliphatic signals
of only four protons belonging to a benzylic bridge between
the A- and B-rings, similar to that of 1 and 2 (Figure S26,
Supporting Information). The protons of the D-ring (H-10′,
H-12′, and H-13′), for which the connectivity was established
according to the COSY correlations (Figure S29, Supporting
Information), exhibited a coupling pattern typical for a 1,3,4-
trisubstituted benzene ring, and their signals were shifted
signiﬁcantly toward lower ﬁelds, especially the one found at δH
8.94 (d, J = 9.0 Hz, H-13′). This was due to the combination
of the strong resonance and anisotropic eﬀect of the C-ring
(Figure S25, Supporting Information). The mutual COSY
correlation of the two doublets found at δH 7.40 (H-7′) and
7.50 (H-8′) and their NOE correlations H-7′/H-5′ and H-8′/
H-10′ referred to the phenanthrene moiety including the C-
and D-rings. The strong NOE correlation H-13′/H-6 of the A-
ring conﬁrmed the proximity of the A- and D-rings as a
consequence of the phenanthrene substructure (Figures S29,
S30, Supporting Information). The H-5′ singlet (δH 7.18)
exhibited a NOE correlation with H-7′ (δH 7.49), which,
together with the HMBC cross-peaks H-5′/C-1′, C-3′, C-7′
conﬁrmed the position of the C-ring protons (Figures S30,
S33, Supporting Information). The HSQC spectrum and
remaining HMBC correlations (Figures S31−S34, Supporting
Information) indicated a new phenanthrene-perrottetin-type
Table 2. 1H and 13C NMR Data of Compounds 4−7 (500 MHz for 1H and 125 MHz for 13C)a
4b 5b 6b 7b
position δC δH δC δH δC δH δC δH
1 154.7 155.7 153.7 153.5
2 123.3 6.66−6.75 mg 113.3 5.72 dd (8.5; 2.0) 122.4c 6.56 dd (8.0; 2.0)c 122.6c 6.77 d (8.0)
3 130.6 6.94 mc,h 130.9 6.35 dd (8.5; 2.0) 129.1d 7.11 dd (8.0; 2.0)d 129.3d 6.94 d (8.0)c
4 141.5 135.0 140.0 139.6
5 130.6 6.66−6.75 mc,g 128.5 6.25 dd (8.5; 2.0) 130.7d 6.68 dd (8.0; 2.0)d 129.8d 7.05 d (8.0)c
6 123.3 6.66−6.75 mg 117.6 6.80 dd (8.5; 2.0) 122.8c 6.98 dd (8.0; 2.0)c 122.8c 6.84 d (8.0)
7 38.7 2.53 m 38.1 2. 64 td (13.0; 3.5) 37.8 2.80 mg 34.4 2.66 m
2.64 m 2. 86 dt (13.0; 3.5) 3.12 mh 2.84 m
8 36.6 2.73 m 37.8 2.13 td (13.0; 3.5) 34.1 2.75 mg 30.1 2.76 m
3.01 m 2.94 dt (13.0; 3.5) 3.06 mh 2.92 m
9 144.8 142.3 142.6 145.6
10 117.7 6.86 d (2.5) 116.4 6.88 d (2.5) 121.9 6.98 d (8.0) 188.3
11 158.0 156.5 130.5 7.28 t (8.0) 137.2f 6.88 d (9.0)g
12 114.3 6.67 dd (7.5; 2.5) 127.8 6.70 dd (8.5; 2.5) 112.6 6.72 d (8.0) 136.8f 6.88 d (9.0)g
13 133.8 6.94 d (7.5)h 132.5 6.67 t (8.5) 155.0 186.8
14 131.3 129.8 121.1 142.4
1′ 136.1 141.7 147.4 147.2
2′ 154.0 144.2 148.8 148.9
3′ 110.6 4.83 d (2.0) 116.3 117.1 5.78 d (2.0) 116.7 5.38 d (2.0)
4′ 138.4 132.5 133.0 133.9
5′ 110.8 6.35 (2.0) 109.5 7.20 s 122.1 6.81 dd (8.5; 2.0) 121.8 6.77 dd (8.0; 2.0)
6′ 151.7 148.5 112.9 6.96 d (8.5) 112.1 6.89 d (8.0)g
7′ 39.4 2.85 m 127.0 7.50 d (9.0) 31.6 2.50 ddd (14.0; 12.0; 2.0) 37.1 2.65 m
2.93 m 2.90 ddd (14.0; 7.0; 2.0) 2.79 m
8′ 39.0 2.53 m 126.1 7.41 d (9.0) 33.1 2.04 ddd (14.0; 12.0; 2.0) 37.9 2.49 m
2.64 m 3.06 mh 2.81 m
9′ 142.4 130.4 146.0 144.4
10′ 121.9 6.11 dd (7.5; 1.5) 121.0 188.0 121.4 6.53 dd (8.5; 2.0)
11′ 133.6 6.74 (7.5) 130.0 7.21 s 135.4 6.48 s 129.8 6.77 d (8.0)
12′ 127.4 113.8 122.1 118.0
13′ 154.8 150.8 185.7 152.7
14′ 117.1 6.28 d (1.5) 110.2 6.98 s 135.7 5.96 s 118.1 6.14 d (2.0)
OMe-1′ 61.5 3.87 s 62.1 4.02 s 55.9 3.93 s 56.3 3.94 s
aJ values are given in parentheses. bCompounds 4 and 6 were recorded in CD3OD, compound 5 in the mixture CD3OD/CDCl3, and compound 7
in CDCl3.
c,d,e,fSignals are interchangable. g,hSignals overlapped.
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structure with an intramolecular C-3′−C-14′ coupled
perrottetin F unit dehydrogenated at C-7′ and C-8′ (Figure 1).
Compound 4 was obtained as a brown amorphous solid. Its
molecular formula, C29H26O5, was deduced by the [M − H]−
molecular ion peak at m/z 453.1716 in its negative-mode
HRESIMS in combination with the 13C NMR spectrum. The
presence of an aromatic system in 4 was also supported by the
UV absorption bands at 252 (sh), 284 and 292 nm (sh) and IR
band at 3214 cm−1. The chemical shifts and coupling constants
of the 1H NMR spectrum of 4 resembled those of riccardin F
except for the C-ring, indicating that compound 4 possesses an
additional hydroxy group in the C-ring of a riccardin F
skeleton (Figure S45, Supporting Information). This supposi-
tion was conﬁrmed by the following spectroscopic data. The
1H NMR spectrum of 4 exhibited a one-proton doublet (δH
4.83, J = 2.0 Hz), characteristic for H-3′, which appeared at
very high ﬁeld due to the anisotropic eﬀect of the A-ring, as
previously observed in cyclic bisbibenzyls of the riccardin and
Chart 1
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marchantin series (Figure S35, Supporting Information). The
COSY correlation H-3′/H-5′ and the HMBC correlations H-
3′/C-5′, C-1′; H-5′, OMe-1′/C-1′ revealed the presence of a
methoxy group at C-1′ (the same as that in riccardin F), while
the presence of two doublets (δH 4.83 and 6.35, H-3′ and H-5′,
respectively) with couplings of 2.0 Hz indicated an additional
OH substituent at C-6′ of ring C. This was conﬁrmed by the
HMBC correlation at H-5′/C-6′ (Figures S39, S43, Supporting
Information). Thus, the structure of 4 was established as 6′-
hydroxyriccardin F, a new derivative of riccardin F.
Compound 5, a violet solid, was found to have the molecular
formula C29H22O5, according to a negative-mode HRESIMS
with a [M − H]− molecular ion peak at m/z 449.1402 as well
as the 13C NMR spectrum. Similar to 3, the UV bands at 225,
270, 318 (sh), 352, and 370 nm and the IR absorptions at 3429
and 1615 cm−1 suggested the presence of a phenolic group and
extended conjugation. The almost identical chemical shifts of
two doublets of H-7′ and H-8′ and a singlet of H-5′ with those
of the same protons in 3, together with similarity of the UV
data, supported the occurrence of a phenanthrene moiety in 5
incorporating the C- and D-rings. This was conﬁrmed by the
HMBC correlations between H-8′/C-10′, C-14′, C-9′ as well
as H-7′/C-3′, C-4′, C-5′, C-9′ and the NOESY cross-peaks of
H-14′/H-8′ and of H-7′/H-5′ (Figures S48 , S51, and
S54, Supporting Information). Additionally, the HMBC
correlations between H-11′, H-10/C-14 and H-13′, H-14/C-
12 conﬁrmed a riccardin skeleton for 5, the same as in 4. The
strong HMBC correlations OMe-1′, H-5′/C-1′ conﬁrmed the
position of the methoxy group at C-1′, and since the proton
signal of H-5′ was a singlet, it was deduced that an additional
OH group is located at C-6′. This assumption was also
conﬁrmed by the HMBC correlation of H-5′/C-6′ (Figures
S54 and S55, Supporting Information). Analyses of the COSY,
NOESY, and HMBC spectra showed that compound 5 has the
same substitution pattern of the A- and B-rings as seen in the
riccardin series. Contrary to 4, the proton signals of the A-ring
appeared as sharp doublets of doublets, suggesting that
compound 5 has a strained structure due to the riccardin-
phenanthrene moiety. The strong anisotropic eﬀect of a
phenanthrene moiety explained the very low chemical shifts
observed for H-8b and H-7b (Figure S47, Supporting
Information). In comparison to 4, it could be proposed that
5 occurs from intramolecular phenolic oxidative coupling
(cyclization) of 4 (6′-hydroxyriccardin F) via the connection
of C-10′ to C-3′, followed by dehydrogenation at C-7′ and C-
8′. For 3, a twisted coupling of C-14′ to C-3′ in perrottetin F
occurs (Figure 1). The diﬀerence between H-2 and H-6, as
well as H-3 and H-5, in the 1H NMR spectrum was determined
Figure 1. Proposed intramolecular oxidative coupling connections involved in the formation of compounds 2, 3, and 5.
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by the strong H-11′/H-6 and the weak H-11′/H-5 NOE
correlation. Thus, compound 5 represents a new secondary
metabolite very similar to the phenanthrene bisbibenzyl
angustatin A, which was isolated from the Chinese liverwort
Asterella angusta,27 and to the highly strained cavicularin,
isolated from the Japanese liverwort Cavicularia densa, resulting
from the intramolecular cyclization in riccardin C.1
Compound 6, an amorphous orange compound, gave the
molecular formula C29H24O5, as established by the negative-
mode HRESIMS ([M − H]− ion peak at m/z 451.1556) and
the 13C NMR spectrum. The NMR spectroscopic data of 6
resembled those of riccardin G, except for the presence of a
para-quinone moiety, as conﬁrmed by the strong UV
absorption bands at 234, 285, 320, 352, and 370 nm, the IR
absorptions at 1611, 1581, and 1655 cm−1, and the presence of
two signals for carbonyl carbon atoms (δC 185.7 and 188.0) in
the 13C NMR spectrum. The connectivity between the C-ring
and the para-quinone D-ring in 6 was established by the NOE
correlations H-3′, H-5′/C-7′ and the HMBC cross-peaks H-7′,
H-11′/C-9′ and H-8′/C-10′, C-14′. The location of the para-
quinone group was determined by the very low chemical shifts
of H-8′b and H-7′b that appeared in the 1H NMR spectrum,
because of the diamagnetic anisotropic eﬀect of the C-10′
carbonyl group. A methoxy group apparent at δH 3.93 was
ascribed to the C-1′ position according to the HMBC cross-
peaks OMe-1′, H-3′, H-5′/C-1′ and the NOE correlation H-
6′/OMe-1′ (Figures S62, S66, and S67, Supporting Informa-
tion). The triplet found at δH 7.28 (J = 8.0 Hz) of H-11 was
connected by COSY correlations to the doublet of H-10 and
the doublet of doublets of H-12. According to the HMBC
correlations, especially H-11′/C-14, a riccardin-type connec-
tion between C-14 and C-12′ of the B- and D-ring was
determined. The protons of the A-ring, instead of the
characteristic AA′BB′ pattern typical for a para-disubstitued
benzene ring, exhibited two pairs of doublets of doublets. This
was in accordance with the restricted mobility of the A-ring,
leading to the chemical nonequivalence of protons H-2 and H-
6, as well as of H-3 and H-5. Moreover, the occurrence of
positive correlations in phase-sensitive NOESY cross-peaks H-
2/H-6 and H-3/H-5 (Figure S63, Supporting Information)
indicated a slow equilibrium between two equivalent
conformations of the A-ring (Figure 2). HMBC and NOE
correlations distinguished the pairs of protons H-2/H-6 to H-
3/H-5 (HMBC: H-2, H-6/C-4; H-3, H-5/C-1; NOE: H-2, H-
6/H-3′), but an exact determination of the positions of their
signals was not determined. Based on the spectroscopic data
described above, the structure of 6 was proposed as that of a
new secondary metabolite, riccardin G 10′,13′-paraquinone.
Compound 7, an amorphous yellow solid, gave the same
molecular formula, C29H24O5 ([M − H]− ion peak at m/z
451.1541; identiﬁed by negative-mode HRESIMS), as that of
6. The UV (236, 285, 35, and 370 nm), IR (1640 cm−1), and
the 1H and 13C NMR spectra were similar to those of 6.
Contrary to 6, compound 7 was not completely soluble in
CD3OD and its NMR spectra were recorded in CDCl3 and in a
combination of CDCl3 and CD3OD. The
13C NMR spectrum
of 7 also revealed two carbonyl carbon atom signals (δC 186.8
and 188.3, Table 2, Figure S70, Supporting Information). The
observed HMBC (H-7/C-3, C-5, C-9 and H-8/C-10) and
COSY correlations (H-7/H-8) were used to connect these two
carbonyls with the protons of a benzyl “bridge” (H2-7 and H2-
8) between the A- and B-rings, suggesting a quinone moiety in
the B-ring. HMBC correlations observed between H2-8, H-12/
C-10 and H-11/C-13 (Figures S72, S76, S78, and
S79, Supporting Information) conﬁrmed this assignment.
The position of the methoxy group (3H-singlet, δH 3.94)
was assigned to C-1′ by the same correlations as shown for 6.
A characteristic cyclic bisbibenzyl doublet of H-3′ found at δH
5.38 (J = 2.0 Hz) exhibited HMBC cross-peaks H-3′/C-1′, C-
5′, C-7′ and together with the COSY H-5′/H-6′ correlation
revealed a 1′,2′,4′-substitution pattern of the C-ring (Figures
S72, S76, and S78, Supporting Information). The HMBC
correlations H-10′/C-8′, C-12′, C-14′ and H-14′/C-8′, C-10′,
C-12′ supported a 9′,12′,13′-substitution pattern of the D-ring.
The strong HMBC correlation between H-11′/C-14 supported
a riccardin-type C-12′−C-14 connection in 7. The same
rationale for the restricted mobility of the-A-ring (as for 6) was
also valid for 7. The H-2 and H-6, and H-3 and H-5 pairs of
protons are chemically nonequivalent. The occurrence of
positive cross-peaks in phase-sensitive NOESY H-2/H-6 and
H-3/H-5 (Figure S73, Supporting Information) indicated a
slow equilibrium between two equivalent conformations of the
A-ring (Figure 2). Consequently, the structure of 7 was
characterized as riccardin G 10,13-para-quinone. Similar
bisbibenzyl C-10,13 para-quinones, isoriccardinquinones A
and B, with a C-12−C-11′ biphenyl linkage and the same type
of para-quinone, marchantiaquinone, with a C-14−O−C-11′
linkage, have been found in the liverworts Marchantia paleacea
and Reboulia hemisphaerica, respectively.1
It is noteworthy that most of the newly isolated bisbibenzyls,
although without stereocenters (all except 1), possess optical
activity: compound 1 exhibited [α]22D −3.3 (c 1.0, MeOH), 2
[α]22D +2.0 (c 1.0, MeOH), 4 [α]
22
D +6.0 (c 1.0, MeOH), 5
[α]22D −33.0 (c 1.0, MeOH), 6 [α]22D −8.0 (c 1.0, MeOH),
and 7 [α]22D −1.0 (c 1.0, MeOH). Compound 5 exhibited the
highest value of −33.0, although there is no chiral center in this
molecule, suggesting a highly strained conformation. This
phenomenon suggested that compound 5 has both planar and
axial chirality, as has been seen in cavicularin.1
The methanol extract of L. cruciata was not cytotoxic against
either the A549 or MRC5 cell line even at a concentration of
200 μg/mL (results not shown). The IC50 values of all isolated
compounds against two diﬀerent cell lines were between 3 and
200 μM, without pronounced selectivity between normal and
cancer cell lines except for 2 and 1, with SI indices 6 and 4,
respectively (Table S2, Supporting Information). The most
potent cytotoxicity was exhibited by the known riccardin G,
with IC50 values of 2.5 μM for A549 and 7.5 μM for MRC5
cells, and the new compounds 5, with IC50 values of 5.0 μM for
A549 and 3.0 μM for MRC5 cells, and 3, with IC50 values of
5.0 μM for both A549 and MRC5 cells. Cisplatin used as the
positive control exhibited IC50 values of 2.5 μM for A549 cells
and 3.5 μM for MRC5 cells. Both 5 and 3 possess a
phenanthrene moiety, and further investigation of cytotoxic
activity of synthetic bisbibenzyls with phenanthrene moieties
Figure 2. A-ring in 6 and 7 slowly exchanging between two equivalent
conformations.
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should be considered. All other compounds were less active or
inactive (IC50 = 10 μM or >10 μM) for both cell lines (Table
S2, Supporting Information).
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
measured on a Rudolph Research Analytical Autopol IV automatic
polarimeter with methanol as solvent, and the compound
concentration used was 1.00 mg/mL. UV spectra were recorded on
a GBC Cintra UV/vis spectrometer with methanol as solvent in the
concentration range 3−9 × 10−5 M. IR spectra were obtained on a
Thermoscientiﬁc Nicolet 6700 FT-IR spectrometer. NMR spectra
were recorded on a Bruker Avance III 500 spectrometer at 500.26
MHz for 1H and 125.80 MHz for 13C, with CD3OD as a solvent.
HRESIMS data were obtained on an Agilent 6210 time-of-ﬂight LC/
MS system equipped with an ESI interface (ESITOFMS). The solvent
was methanol, and the mobile phase was 0.2% HCOOH/CH3CN,
1:1, 0.2 mL/min. The ESI was operated in a negative mode, and
nitrogen was used as the drying gas (12 L/min) and nebulizing gas at
350 °C (45 psi). The OCT RF voltage was set to 250 V, and the
capillary voltage was set to 4.0 kV. The voltages applied to the
fragmentor and skimmer were 140 and 60 V, respectively. Scanning
was performed from m/z 100 to 1500. Column chromatography
(CC) was performed on silica gel 60 (0.063−0.200 mm, Merck).
Analytical TLC was carried out on silica gel 60 GF254 20 × 20 cm
plates, with a layer thickness of 0.25 mm (Merck). Preparative TLC
was carried out on silica gel 60 GF254 (<0.063 mm, Merck)-packed
20 × 20 cm plates, thickness 0.75 mm. Semipreparative HPLC
separation was performed on an Agilent Instrument 1100 series
equipped with a DAD (Agilent Technologies, G1315C). The column
used was a Zorbax Eclipse XDB C18 (9.4 mm × 250 mm, 5 μm).
Solvents for HPLC separation were of chromatographic grade.
Solvents for CC were freshly distilled.
Plant Material. The plant material was collected in Cesena, Italy,
in a city park below the fortress (Rocca Malatestiana, coordinates:
44.136195° N 12.239885° E), in September 2016, and was identiﬁed
by one of the authors (M.V.). The samples were dried at room
temperature. A voucher specimen (No. 17290) has been deposited in
the Herbarium at the Institute of Botany and Botanical Garden
“Jevremovac”, University of Belgrade (BEOU), Belgrade, Serbia.
Extraction and Isolation. The air-dried liverwort Lunularia
cruciata (100 g) was milled and extracted initially with n-hexane and
then with CH3OH (4 × 1 L, 48 h) at room temperature, using an
ultrasonic bath. After evaporation of the solvents, the crude methanol
extract (10.3 g) was fractionated by silica gel CC (700 × 50 mm)
using gradient elution with n-hexane/ethyl acetate mixtures having
increasing percentages of ethyl acetate (Table S1, Supporting
Information). Similar fractions (volumes 20−25 mL) were combined
according to TLC and further separated ﬁrst by preparative silica gel
TLC (elution systems diﬀerent ratios CH2Cl2/MeOH) and later by
semipreparative HPLC using a C18 column and a DAD (254, 280
nm). The eluent was H2O/CH3CN and the ﬂow rate 4 mL/min. The
basic HPLC program was as follows: 0−12 min, 30% CH3CN; 12−25
min, 30−100% CH3CN; 25−30 min, 100% CH3CN. After separation
by preparative silica gel TLC (with CH2Cl2/MeOH, 96:4) and
additional separation by semipreparative HPLC, 7 mg of riccardin F
(tR 23.2 min), 5 mg of riccardin G (tR 24.2 min), 2 mg of 6 (tR 23.4
min), and 6 mg of 7 (tR 23.7 min) were isolated from collected
fractions 211−225. From the combined fractions 226−232 and their
diﬀerent subfractions obtained after preparative TLC (with CH2Cl2/
MeOH, 96:4) and semipreparative HPLC, 42 mg of lunularin (tR 17.7
min), 33 mg of perrottetin E (tR 21.9 min), 278 mg of perrottetin F
(tR 20.5 min), 3 mg of 2 (tR 19.2 min), 5 mg of 5 (tR 20.0 min), 3 mg
of 3 (tR 21.4 min), and 8 mg of riccardin C (tR 21.7 min) were
obtained. Compound 1 was isolated in the amount of 2 mg from the
combined fractions 233−245 in the same manner (tR 20.9 min). Prior
to the investigation of the biological activity, the purity of all
compounds was checked by HPLC-DAD at 280 nm and by NMR
spectroscopy. The purity was 98% and greater for all isolated
compounds.
Compound 1: brown, amorphous solid; [α]22D −3.3 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 220 (4.20), 272 (3.86), 282 sh
(3.84) nm; IR (KBr) νmax 3422, 2927, 2856, 1609, 1600, 1593, 1455,
1340, 1216, 1167, 1078, 1027, 979 cm−1; 1H NMR and 13C NMR, see
Table 1; HRESIMS m/z 471.1827 [M − H]− (calcd for C29H28O6 −
H, 471.1813).
Compound 2: pale violet, amorphous solid; [α]22D +2.0 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 212 (4.27), 278 (3.94), 294 sh
(3.68), 320 (3.68) nm; IR (KBr) νmax 3451, 3033, 2929, 2855, 1610,
1504, 1474, 1455, 1354, 1257, 1235, 1166, 1128, 1105, 1017, 964,
890, 855, 821 cm−1; 1H NMR and 13C NMR, see Table 1; HRESIMS
m/z 423.1610 [M − H]− (calcd for C28H24O4 − H, 423.1602).
Compound 3: violet, amorphous solid; [α]22D 0 (c 1.0, MeOH);
UV (MeOH) λmax (log ε) 224 (4.46), 256 (4.69), 272 sh (4.44), 284
sh (4.27), 308 sh (3.76), 344 (3.22), 362 (3.27) nm; IR (KBr) νmax
3374, 2925, 2854, 1614, 1588, 1504, 1474, 1456, 1434, 1365, 1276,
1228, 1164, 1119, 1033, 1012, 963, 868 cm−1; 1H NMR and 13C
NMR, see Table 1; HRESIMS m/z 437.1405 [M − H]− (calcd for
C28H22O5 − H, 437.1394).
Compound 4: brown, amorphous solid; [α]22D +6.0 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 212 (4.75), 252 sh (4.06), 284
(3.90), 292 sh (3.83) nm; IR (KBr) νmax 3241, 3030, 2934, 2860,
2838, 1650, 1606, 1590, 1564, 1505, 1435, 1351, 1291, 1217, 1168,
1042, 998, 852, 835, 814 cm−1; 1H NMR and 13C NMR, see Table 2;
HRESIMS m/z 453.1716 [M − H]− (calcd for C29H26O5 − H,
453.1707).
Compound 5: violet, amorphous solid; [α]22D −33.0 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 225 (4.42), 270 (4.51), 318 sh
(3.84), 352 (3.20), 370 (3.23) nm; IR (KBr) νmax 3429, 2925, 2855,
1615, 1606, 1559, 1501, 1464, 1445, 1426, 1410, 1383, 1354, 1287,
1220, 1178, 1164, 1123, 1104, 1041, 1021, 998, 867, 822 cm−1; 1H
NMR and 13C NMR, see Table 2; HRESIMS m/z 449.1402 [M −
H]− (calcd for C29H22O5 − H, 449.1394).
Compound 6: orange, amorphous solid; [α]22D −8.0 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 236 (4.44), 255 sh (4.34), 264 sh
(4.29), 285 (3.94), 320 (3.16), 352 (3.20), 370 (3.23) nm; IR (KBr)
νmax 3445, 3271, 3028, 2927, 2854, 1655, 1631, 1611, 1581, 1515,
1506, 1462, 1447, 1421, 1340, 1264, 1234, 1212, 1165, 1128, 1100,
1018, 976, 853, 788, 753 cm−1; 1H NMR and 13C NMR, see Table 2;
HRESIMS m/z 451.1556 [M − H]− (calcd for C29H24O5 − H,
451.1551).
Compound 7: orange, amorphous solid; [α]22D −1.0 (c 1.0,
MeOH); UV (MeOH) λmax (log ε) 238 (4.34), 258 sh (4.24), 282
(4.01), 392 (3.35) nm; IR (KBr) νmax 3463, 3058, 3033, 2933, 2855,
1654, 1616, 1590, 1514, 1443, 1424, 1334, 1297, 1265, 1232, 1216,
1166, 1129, 1071, 1019, 937, 844 cm−1; 1H NMR and 13C NMR see
Table 2; HRESIMS m/z 451.1541 [M − H]− (calcd for C29H24O5 −
H, 451.1551).
Cytotoxicity Assays. Cytotoxicity (antiproliferative activity) of
the plant methanol extract and the isolated pure compounds was
determined using a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) reduction assay.28 Brieﬂy, A549
(human lung carcinoma, obtained from ATCC) and MRC5 cells
(human lung ﬁbroblast, obtained from ATCC) were plated in a 96-
well ﬂat-bottom plate at a concentration of 1 × 104 cells per well,
grown in a humidiﬁed atmosphere of 95% air and 5% CO2 at 37 °C,
and maintained as monolayer cultures in RPMI-1640 medium,
supplemented with 100 μg/mL streptomycin, 100 U/mL penicillin,
and 10% (v/v) fetal bovine serum (FBS). After a 24 h incubation
period of MRC5 and A549 cells, medium containing increasing
concentrations of each tested compound (μM) was added to the cells.
Control cultures received the solvent DMSO, and blank wells
contained 200 μL of growth medium. Cisplatin (cis-
diammineplatinum(II) dichloride; Sigma-Aldrich) was used as a
positive control. After 24 h of incubation, the MTT reduction assay
was carried out and cell proliferation was determined from the
absorbance at 540 nm on a Tecan Inﬁnite 200 Pro multiplate reader
(Tecan Group, Man̈nedorf, Switzerland). The MTT assay was
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performed three times in quadruplicate for each test compound
concentration, and the results are presented as a percentage of the
control (untreated cells) that was arbitrarily set to 100%.
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